↓ Skip to main content

β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms

Overview of attention for article published in Frontiers in Pharmacology, September 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (64th percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
β-caryophyllene, an FDA-Approved Food Additive, Inhibits Methamphetamine-Taking and Methamphetamine-Seeking Behaviors Possibly via CB2 and Non-CB2 Receptor Mechanisms
Published in
Frontiers in Pharmacology, September 2021
DOI 10.3389/fphar.2021.722476
Pubmed ID
Authors

Xiang-Hu He, Ewa Galaj, Guo-Hua Bi, Yi He, Briana Hempel, Yan-Lin Wang, Eliot L. Gardner, Zheng-Xiong Xi

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 4 17%
Other 2 9%
Professor > Associate Professor 2 9%
Student > Ph. D. Student 2 9%
Unspecified 1 4%
Other 2 9%
Unknown 10 43%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 13%
Neuroscience 3 13%
Agricultural and Biological Sciences 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Unspecified 1 4%
Other 1 4%
Unknown 10 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2023.
All research outputs
#7,478,918
of 23,500,709 outputs
Outputs from Frontiers in Pharmacology
#3,242
of 17,055 outputs
Outputs of similar age
#149,204
of 430,880 outputs
Outputs of similar age from Frontiers in Pharmacology
#138
of 983 outputs
Altmetric has tracked 23,500,709 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 17,055 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 430,880 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 983 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.